ONCOLOGY
About the journal
ONCOLOGY is a journal in United States. It is listed in MEDLINE and PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- ISSN
- 0890-9091
- Country
- United States
- Access
- Not open access / not declared
- Official website
- http://www.cancernetwork.com/library/oncology.htm
Index listings
- MEDLINE · 1987-01-01
- PUBMED · 1997-02-01
- Indexing
- MEDLINE · PUBMED
- APC
- —
- Declared review time (DOAJ)
- —
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
360
Last recorded publication year
2025
h-index
15
i10-index
26
From OpenAlex open data (CC0).
Editorial & policy3
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 20%
- ORCID iDs in current deposits
- 0%
- Deposits licence metadata at Crossref
- ✓
Identity & continuity3
- Alternate titles
- Oncology journalCancer Network oncology
- Source type
- journal
- NLM unique ID (PubMed)
- 8712059
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Lymphoma Diagnosis and Treatment
- Economic and Financial Impacts of Cancer
- Lymphoma Diagnosis and Treatment
- Economic and Financial Impacts of Cancer
Show all subjects (50)
- Multiple Myeloma Research and Treatments
- Multiple Myeloma Research and Treatments
- Lung Cancer Treatments and Mutations
- CAR-T cell therapy research
- Lung Cancer Treatments and Mutations
- CAR-T cell therapy research
- COVID-19 and healthcare impacts
- COVID-19 and healthcare impacts
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- Sarcoma Diagnosis and Treatment
- Sarcoma Diagnosis and Treatment
- Cancer Diagnosis and Treatment
- Cancer Diagnosis and Treatment
- Prostate Cancer Treatment and Research
- Lung Cancer Research Studies
- Prostate Cancer Treatment and Research
- Lung Cancer Research Studies
- Chronic Lymphocytic Leukemia Research
- Advances in Oncology and Radiotherapy
- Chronic Lymphocytic Leukemia Research
- Advances in Oncology and Radiotherapy
- Colorectal and Anal Carcinomas
- Advanced Breast Cancer Therapies
- PARP inhibition in cancer therapy
- Genetic factors in colorectal cancer
- Renal cell carcinoma treatment
- Genetic factors in colorectal cancer
- Renal cell carcinoma treatment
- PARP inhibition in cancer therapy
- Colorectal and Anal Carcinomas
- Advanced Breast Cancer Therapies
- Cancer survivorship and care
- BRCA gene mutations in cancer
- Bladder and Urothelial Cancer Treatments
- Cancer survivorship and care
- BRCA gene mutations in cancer
- Bladder and Urothelial Cancer Treatments
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ